ORLANDO, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 20.792
AS - Asia 8.291
EU - Europa 8.082
SA - Sud America 1.148
Continente sconosciuto - Info sul continente non disponibili 258
AF - Africa 241
OC - Oceania 24
Totale 38.836
Nazione #
US - Stati Uniti d'America 20.098
GB - Regno Unito 2.800
SG - Singapore 2.514
CN - Cina 2.063
IT - Italia 1.609
HK - Hong Kong 918
VN - Vietnam 889
BR - Brasile 850
SE - Svezia 845
DE - Germania 696
BD - Bangladesh 413
FI - Finlandia 404
CA - Canada 387
RU - Federazione Russa 381
FR - Francia 353
TR - Turchia 324
UA - Ucraina 312
IN - India 241
KR - Corea 218
BG - Bulgaria 138
ID - Indonesia 128
NL - Olanda 103
MX - Messico 99
ZA - Sudafrica 86
AR - Argentina 80
IQ - Iraq 75
JP - Giappone 63
ES - Italia 58
IL - Israele 56
LT - Lituania 55
PK - Pakistan 55
CO - Colombia 53
PL - Polonia 53
CR - Costa Rica 47
AE - Emirati Arabi Uniti 43
CL - Cile 41
EC - Ecuador 36
IE - Irlanda 35
IR - Iran 35
MA - Marocco 35
BE - Belgio 33
CZ - Repubblica Ceca 32
MY - Malesia 29
SV - El Salvador 28
VE - Venezuela 28
UZ - Uzbekistan 26
TH - Thailandia 24
NP - Nepal 23
PE - Perù 23
PH - Filippine 22
AU - Australia 21
JO - Giordania 21
PY - Paraguay 21
SA - Arabia Saudita 21
AT - Austria 19
JM - Giamaica 19
TT - Trinidad e Tobago 19
HN - Honduras 18
RO - Romania 18
KE - Kenya 16
EU - Europa 15
NG - Nigeria 15
SC - Seychelles 15
SI - Slovenia 15
EG - Egitto 14
GT - Guatemala 14
KZ - Kazakistan 14
NI - Nicaragua 14
PR - Porto Rico 14
DZ - Algeria 13
GP - Guadalupe 13
MD - Moldavia 12
AL - Albania 10
CW - ???statistics.table.value.countryCode.CW??? 10
GE - Georgia 10
GR - Grecia 10
TN - Tunisia 10
DK - Danimarca 9
SN - Senegal 9
BY - Bielorussia 8
CH - Svizzera 8
EE - Estonia 8
HU - Ungheria 8
UY - Uruguay 8
AZ - Azerbaigian 7
LV - Lettonia 7
NO - Norvegia 7
PT - Portogallo 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
QA - Qatar 6
TW - Taiwan 6
ET - Etiopia 5
HR - Croazia 5
KG - Kirghizistan 5
OM - Oman 5
PA - Panama 5
Totale 38.523
Città #
Ashburn 3.168
Southend 2.192
Santa Clara 1.695
Singapore 1.572
Fairfield 1.214
Chandler 1.059
San Jose 953
Hong Kong 902
Woodbridge 854
Houston 628
Council Bluffs 584
Jacksonville 532
Beijing 499
Dearborn 487
Wilmington 469
Nyköping 468
Seattle 461
Hefei 428
Cambridge 406
Los Angeles 388
Chicago 384
Ann Arbor 335
London 327
Dallas 312
Ho Chi Minh City 297
New York 277
The Dalles 247
Helsinki 239
Modena 227
Seoul 189
Hanoi 180
Izmir 178
Princeton 150
San Diego 150
São Paulo 150
Munich 142
Shanghai 136
Milan 135
Salt Lake City 134
Sofia 127
Toronto 125
Buffalo 124
Lauterbourg 112
Eugene 104
Bremen 101
Bologna 87
Moscow 81
Tampa 81
Frankfurt am Main 80
Rome 80
Jakarta 78
Columbus 76
Orem 63
Atlanta 57
Johannesburg 56
Turku 56
Montreal 55
Mumbai 55
Elk Grove Village 54
Phoenix 54
Tokyo 50
Redwood City 49
Des Moines 43
Fremont 43
Warsaw 41
Naples 40
Da Nang 39
Boardman 38
Falls Church 38
Chennai 37
North York 37
Sterling 37
Brooklyn 36
Amsterdam 35
San José 34
Haiphong 33
Mexico City 33
Detroit 32
Denver 31
Rio de Janeiro 31
Stockholm 30
Baghdad 29
Brussels 29
Dublin 28
Guangzhou 28
Parma 28
Washington 28
Lancaster 27
Dong Ket 25
Miami 25
San Francisco 25
Newark 24
Biên Hòa 23
Tashkent 23
Turin 23
North Bergen 22
Norwalk 22
San Salvador 22
Belo Horizonte 21
Boston 21
Totale 26.114
Nome #
Hypertriglyceridemia and Waist Circumference Predict Cardiovascular Risk among HIV Patients: A Cross-Sectional Study 756
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 540
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 524
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 506
Human immunodeficiency virus infection is associated with accelerated atherosclerosis. 488
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 486
Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV 460
Premature age-related comorbidities among HIV-infected persons compared with the general population 457
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 445
GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls 432
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 415
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 408
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 403
High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy 396
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 396
Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients 395
Erectile Dysfunction Is Not a Mirror of Endothelial Dysfunction in HIV-Infected Patients. 390
Ectopic fat is linked to prior cardiovascular events in men with HIV. 381
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 378
Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up. 373
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 371
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 369
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 369
Cost of noninfectious comorbidities in patients with HIV 362
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 355
Hypokalemia in Patients with COVID-19 355
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 349
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. 345
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 344
Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients 343
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 342
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. 341
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 340
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 335
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 330
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 330
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 329
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 326
Re: Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner F, Burger M, May M, MR2 study group (2017) Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol 49:1311–1318 324
Combined Use of Waist and Hip Circumference to Identify Abdominally Obese HIV-Infected Patients at Increased Health Risk 323
Peritoneal dialysis in the time of coronavirus disease 2019 322
Abacavir and Tenofovir impact on endothelial. 312
Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era 311
Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy 310
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. 309
Prevalence of secondary causes of osteoporosis among HIV infected individuals 309
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 309
Surgical correction of HIV-associated facial lipoatrophy. 308
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 304
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 304
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 302
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 302
Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. 301
Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution 298
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 293
Subclinical coronary artery atherosclerosis and endothelial dysfunction are not predictors of erectile dysfunction in HIV-infected males 293
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 293
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 291
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 288
Emphysema is an independent predictor of coronary artery calcium score in a large cohort of HIV infected patients 286
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 286
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 284
Impairment of GH response to GHRH+Arginine in women affected by HIV-related adipose tissue redistribution syndrome (HARS) 284
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 283
Significant chronic airway abnormalities in never-smoking HIV-infected patients 279
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 277
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 276
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 276
CD4 nadir and antiretroviral exposure predict premature polypathology onset 275
Coronary artery calcification is associated with femoral but not with lumbar spine mineral density 269
Erectile dysfunction does not mirror endothelial dysfunction in hiv-infected patients 268
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 266
Bone mineral density and sex hormones in HIV-infected men 266
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 265
Cost of non-infectious co-morbidities in patients with HIV 265
CORONARY AGEING IN HIV INFECTED PATIENTS 265
Prevalence and characterization of hypogonadism among men with human immunodeficiency virus infection: preliminary results 265
Sex steroids and HIV-related osteoporosis in men: low circulating estrogens are associated with impaired bone mineral density (BMD) 264
EAT volume is an independent risk factor of cardiovascular disease in HIV-infected patients 262
Sensitivity and specificity of visceral and epicardial adipose tissue values in the prediction of occult cardiovascular disease in HIV-infected patients. 259
Hypopituitarism and HIV-infection: a new comorbidity in the HAART era? 258
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 256
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 256
Visceral fat but not general adiposity is a predictor of sub-clinical atherosclerosis in HIV-infected patients with lipodystrophy. 254
Erectile dysfunction does not mirror sub-clinical atherosclerosis in HIV infected males. 253
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 253
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 251
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 249
Emphysema is an independent predictor of coronary artery calcium score in a large cohort of HIV-infected patients. 249
Prevalence of secondary, primary, and compensated hypogonadism in HIV infected men in HAART era: a cross-sectional observational study 247
Impaired growth hormone secretion in women with HIV-related lipodystrophy 247
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 244
Testosterone changes over time in men with human immunodeficiency virus infection: preliminary results 241
Impaired GH secretion in women with HIV-related lipodystrophy 241
Testosterone Changes over Time in Men with Human Immunodeficiency Virus Infection: Preliminary Results 241
Gender and gonadal function differences in the prevalence of bone mass reduction 239
Central Nervous System Infections Caused by Bacillus Calmette-Guerin: Case Report and Narrative Literature Review 236
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 234
Premature decline of serum total testosterone in human immunodeficiency virus (HIV) infected men with HIV-related lipodystrophy in the highly active antiretroviral therapy (HAART) era: a cross-sectional observational study 233
Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study. 231
Totale 32.303
Categoria #
all - tutte 143.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.809 0 0 0 0 123 149 186 138 245 191 416 361
2022/20232.889 324 343 250 286 350 428 59 265 341 31 101 111
2023/20241.995 60 113 115 217 385 277 151 186 53 85 125 228
2024/20255.799 138 98 112 428 1.143 856 431 310 735 233 584 731
2025/202611.613 663 402 920 1.364 2.326 658 1.382 487 1.083 1.120 736 472
2026/20274.532 282 976 971 2.080 223 0 0 0 0 0 0 0
Totale 38.836